Lupin gets USFDA nod for generic cancer treatment drug

Lupin in partnership with Pharmascience Inc. has received approval from the US Food and Drug Administration (FDA) for Dasatinib tablets in strengths of 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, it said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/izV0AvL
via IFTTT